Novo Nordisk's oral drug Rybelsus, a version of semaglutide, has shown promising results in reducing the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease and/or chronic kidney disease in a late-stage study.
A recent study revealed associations between cardiometabolic index (CMI), insulin resistance (IR), prediabetes (preDM), and type 2 diabetes mellitus (T2D) in U.S. adults, showing elevated CMI is linked to a higher likelihood of developing IR, preDM, and T2D, with a plateau effect suggesting maintaining CMI at certain levels is beneficial.
New study in BMJ shows no link between fathers' use of metformin and birth defects in children, contradicting previous research findings. Experts attribute the absence of a link to data quality and lack of plausible biological mechanism.
Electronic nudges boosted flu vaccination rates by up to 13.9 percentage points in chronic disease patients, with the most effective reminder doubling the control group’s rate.
Study unveils significant association between familial hypercholesterolemia and type 2 diabetes risk, with obesity as the primary contributor. Higher prevalence observed in the Eastern Mediterranean region.
A 1% increase in PREVENT risk estimates is linked to a 9% rise in cardiovascular mortality, making the model more accurate than traditional methods for predicting 10-year CVD outcomes.